JOEZ, Joe's Jeans Inc.
** For the first quarter of fiscal 2012, JOEZ posted overall net sales of $26.0 million, a 23% increase year over year, and operating income of $1.8 million compared to $523,000 in the same period the prior year.
JOEZ designs, produces and sells apparel and apparel-related products to the retail and premium markets under the Joe's(R) brand and related trademarks.
More about JOEZ at www.joesjeans.com.
PIP, PharmAthene, Inc.
** PIP reported that Dr. Thomas Fuerst, Executive Vice President and Chief Scientific Officer, presented a comprehensive update on PIP's novel SparVax(TM) rPA anthrax vaccine program at the 2012 World Vaccine Congress, held at the Gaylord National Convention Center in Washington, DC, April 11-14, 2012.
PIP's SparVax is being developed to meet the government's need for an improved second generation anthrax vaccine that is safe, convenient, more cost-effective, and capable of providing rapid manufacturing scale-up in response to a national security emergency.
According to PIP, new data based on a recent analysis of previous human clinical trial immunogenicity data and non-clinical animal study results for SparVax suggested a preliminary estimate of efficacy in humans of over 90% protection and nearly 100% protection based on a 6- and 12-month booster dose, respectively. This analysis is based on a correlate of protection established under the Animal Rule in accordance with FDA guidelines.
SparVax is a novel second generation anthrax vaccine being developed to protect against inhalation anthrax, the most lethal form of anthrax infection in humans. The vaccine contains highly purified recombinant protective antigen (rPA) and has been shown to stimulate protection against anthrax by eliciting a specific immune response to one of the primary proteins excreted by the Bacillus anthracis organism.
Unlike the first generation anthrax vaccine and other rPA-based anthrax vaccines in development, SparVax is produced using E. coli, which enables a much more robust and scalable manufacturing process.
PIP was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons.
More about PIP at www.PharmAthene.com.
INWK, InnerWorkings, Inc.
** INWK reported a comprehensive print management agreement with The PNC Financial Services Group, Inc., one of the nation's largest financial services organizations. The multi-year agreement is intended to achieve meaningful cost savings for PNC and foster innovation across the company?s marketing supply chain.
INWK will provide a full range of print management services for PNC, including direct mail, retail point-of-sale materials, new account welcome kits, envelopes, window displays and other marketing collateral. The agreement also is expected to create new opportunities for PNC?s local suppliers to support other INWK?s clients.
INWK is a leading provider of global print management and promotional solutions to corporate clients across a wide range of industries.
More about INWK at www.inwk.com.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.